Dr. Leslie B. Forgosh, MD

Dr. Forgosh practices at Healtheast Professional Services in Saint Paul, Minnesota.

Dr. Forgosh's NPI, 1154305738, was assigned on December 6, 2005. Dr. Forgosh holds Minnesota license 40393.

Dr. Forgosh's primary practice is Healtheast Professional Services, at 1700 University W Ave, Saint Paul, MN 55104 in Ramsey County. The practice phone is (651) 232-2273.

Dr. Forgosh's primary practice is Healtheast Professional Services in Saint Paul, Minnesota. Dr. Forgosh is also affiliated with M Health Fairview Bethesda Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Forgosh to 5 more hospitals, 8 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Forgosh practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Forgosh's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Forgosh is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Forgosh is licensed in Minnesota.

CMS data shows 2,430 Medicare services from Dr. Forgosh across 19 procedure codes in 2024, for 1,390 Medicare patients. Medicare paid $73,109 for them.

CMS counts 1,390 Medicare patients who saw Dr. Forgosh in 2024. The largest group is 75 to 84, with 507 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Forgosh's median patient age at 73, with 43% women.

In 2024, Dr. Forgosh wrote 2,821 Medicare Part D claims for 496 patients. 82% of them were for generic drugs. CMS names the drug for 2,585 of them, across 38 drugs with 11 or more claims each, at $570,258 in total drug cost. In 2023, CMS named 2,639 claims across 39 drugs.

Dr. Forgosh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Forgosh in 2020. Dr. Forgosh's most frequent co-authors are Robert Evan Anderson, MD, Dinesh K. Gupta, MD and Ray Elwin Hershberger, MD.

Dmand AI links Dr. Forgosh to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Diabetes Mellitus, Type 2, Diabetes Mellitus and Homozygous Familial Hypercholesterolemia. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Forgosh that name 4 trials.

CMS Open Payments shows 72 general payments to Dr. Forgosh from 9 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 76% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,087. It also lists 25 research payments totaling $17,753 from 2018 to 2025, naming 4 clinical trials.